CLDX compared with VERA: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

VERAVera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

VERAVera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

CLDXwithVERA

×0.41co-movement · VERA on CLDX · 500d

r 0.29scale to r 0.75

Shared co-movers4with CLDXwith VERA

NRIXNurix Therapeutics, Inc.r 0.44r 0.35

DNLIDenali Therapeutics Inc.r 0.48r 0.34

KURAKura Oncology, Inc.r 0.44r 0.33

XNCRXencor Incr 0.48r 0.33

CLDX, solidVERA, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

CLDXCelldex Therapeutics, Inc.

29.04▼−3.52%· post 29.04

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

VERAVera Therapeutics, Inc.

30.27▼−2.30%· post 30.27

ClosedNov 2 '26

Mkt cap$2.2BRevenue—Revenue—

Compare

ClosedNov 2 '26

CLDXCelldex Therapeutics, Inc.

VERAVera Therapeutics, Inc.

29.04▼−3.52%post 29.04

Price

30.27▼−2.30%post 30.27

$2.3B

Mkt cap

$2.2B

Q2 FY26$22,000

Revenue

—

FY24$7M

Revenue

—

CLDX29.04▼−3.52%vsVERA30.27▼−2.30%ClosedNov 2 '26